| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |